I farmaci che stimolano l’attività del GLP-1, come Ozempic, hanno rivoluzionato il trattamento dell’obesità grazie alla loro efficacia nella perdita di peso. Tuttavia, è essenziale parlare anche dei potenziali effetti collaterali dell’Ozempic, come nausea, vomito, perdita di massa muscolare, pancreatite e, in rari casi, tumori alla tiroide e al pancreas. Senza dimenticare i costi, sia economici che biologici.
Ma c’è un’alternativa? Possiamo stimolare il GLP-1 in modo naturale, tramite alimentazione e stile di vita, evitando gli effetti avversi dei farmaci?
L’esercizio fisico
Cinque studi clinici hanno valutato l’effetto dell’esercizio fisico sui livelli di GLP-1. Quattro di questi hanno mostrato un aumento significativo del GLP-1 in seguito a esercizi ad alta intensità (HIIT), a sprint brevi e anche a esercizi moderati ma continui. Il risultato? L’attività fisica, anche moderata, aumenta i livelli nel sangue, migliorando il senso di sazietà.
Nonostante qualche possibile distorsione nei dati pubblicati (bias di pubblicazione), il messaggio resta valido: muoversi fa bene e stimola ormoni utili al controllo dell’appetito.
Alimentazione e GLP-1: è possibile stimolarlo naturalmente?
Alcuni alimenti e spezie sembrano aumentare la produzione naturale. Ma possono davvero competere con i livelli elevati indotti dai farmaci come l’Ozempic?
I farmaci raggiungono nel sangue concentrazioni di 20–30 nanomoli/litro. Il GLP-1 prodotto naturalmente dopo un pasto? Solo 20–30 picomoli, ovvero mille volte meno. Tuttavia, questo confronto potrebbe ingannare. Quello naturale viene rapidamente inattivato nel sangue e i prelievi venosi possono sottostimare i livelli reali che raggiungono i recettori nel corpo.
Inoltre, i farmaci come l’Ozempic sono progettati per legarsi a proteine plasmatiche, restando in circolo più a lungo ma rendendo solo una piccola frazione del GLP effettivamente attiva. Risultato? I livelli “attivi” dei farmaci potrebbero essere più simili a quelli naturali di quanto sembri.
Come agisce il GLP-1 nel nostro corpo?
Il GLP agisce principalmente sul cervello, riducendo l’appetito. Ma non deve per forza arrivare lì attraverso il sangue: il nervo vago connette direttamente intestino e cervello, permettendo al GLP-1 di inviare segnali di sazietà senza attraversare la barriera ematoencefalica. Ecco perché anche piccoli aumenti naturali possono avere effetti clinici significativi.
Quali alimenti funzionano davvero?
Una revisione recente ha elencato numerosi alimenti e spezie che potrebbero stimolarlo: berberina (nelle bacche di crespino), quercetina (nei capperi e cipolle rosse), tè verde, zenzero, curcuma, cannella, e resveratrolo (nell’uva). Ma molti di questi effetti sono stati osservati solo su topi o in vitro.
Ecco alcuni esempi:
-
Soia: aumenta il GLP… nei topi.
-
Gardenia e ginseng: promettenti nei roditori, ma i dati sull’uomo mancano o sono negativi.
-
Resveratrolo: efficace nei ratti, non negli esseri umani.
-
Tè verde: aumento non significativo negli studi clinici.
-
Avocado: contrariamente alla narrativa popolare, ha ridotto il GLP nei pasti testati.
La berberina, spesso chiamata “Ozempic naturale”, ha mostrato effetti stimolanti nei topi, ma nessuna prova clinica sull’uomo ha confermato benefici sulla perdita di peso.
Il potere della masticazione
Sorprendentemente, masticare più a lungo aumenta i livelli di GLP-1. Uno studio ha mostrato che chi masticava ogni boccone 40 volte (contro 15) ne produceva di più e assumeva circa 75 kcal in meno.
Anche la consistenza del cibo conta: cavolo tagliato a pezzi (che richiede più masticazione) ha aumentato il GLP-1 più del cavolo frullato. E non è solo la masticazione: mangiare lentamente, come dimostrato con studi sul consumo di gelato in 5 contro 30 minuti, ha portato a un aumento del GLP fino al 30%.
Negli adulti obesi, però, l’effetto del mangiare lentamente è meno marcato rispetto agli adolescenti obesi o agli adulti in sovrappeso.
E le spezie?
Un altro studio ha confrontato tre versioni dello stesso pasto: una insipida, una con spezie moderate e una molto speziata. Le spezie usate includevano curcuma, coriandolo, cumino, amla, pepe di cayenna, cannella e chiodi di garofano. Risultato? Le versioni speziate hanno aumentato il GLP-1 del 17% e 32% rispetto alla versione neutra.
Conclusioni
Sebbene i farmaci come l’Ozempic possano indurre livelli di GLP-1 molto elevati, modificare dieta e abitudini può aumentare naturalmente il GLP-1 in modo sufficiente a ridurre l’appetito e aiutare nella gestione del peso — senza gli effetti collaterali dell’Ozempic.
Piccoli accorgimenti come:
-
fare attività fisica regolare,
-
masticare più a lungo,
-
mangiare lentamente,
-
integrare spezie specifiche nella dieta
…possono contribuire in modo significativo.
Fonti
- Yaribeygi H, Jamialahmadi T, Moallem SA, Sahebkar A. Boosting GLP-1 by natural products. Adv Exp Med Biol. 2021;1328:513-522.
- Moyad MA. Embracing the pros and cons of the new weight loss medications (semaglutide, tirzepatide, etc.). Curr Urol Rep. 2023;24(11):515-525.
- Hu M, Kong Z, Shi Q, Nie J. Acute effect of high-intensity interval training versus moderate-intensity continuous training on appetite-regulating gut hormones in healthy adults: a systematic review and meta-analysis. Heliyon. 2023;9(2):e13129.
- Warburton DER, Bredin SSD. Health benefits of physical activity: a strengths-based approach. J Clin Med. 2019;8(12):2044.
- Smits MM, Holst JJ. Endogenous glucagon-like peptide (GLP)-1 as alternative for GLP-1 receptor agonists: could this work and how? Diabetes Metab Res Rev. 2023;39(8):e3699.
- Holst JJ. Glucagon-like peptide-1: are its roles as endogenous hormone and therapeutic wizard congruent? J Intern Med. 2022;291(5):557-573.
- Dowsett GKC, Yeo GSH. Are GLP-1R agonists the long-sought-after panacea for obesity? Trends Mol Med. 2023;29(10):777-779.
- Karhunen LJ, Juvonen KR, Huotari A, Purhonen AK, Herzig KH. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept. 2008;149(1-3):70-78.
- Müller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019;30:72-130.
- Gutzwiller JP, Göke B, Drewe J, et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut. 1999;44(1):81-86.
- Mars M, Stafleu A, de Graaf C. Use of satiety peptides in assessing the satiating capacity of foods. Physiol Behav. 2012;105(2):483-488.
- Lim JJ, Poppitt SD. How satiating are the “satiety” peptides: a problem of pharmacology versus physiology in the development of novel foods for regulation of food intake. Nutrients. 2019;11(7):1517.
- Yaribeygi H, Jamialahmadi T, Moallem SA, Sahebkar A. Boosting GLP-1 by natural products. Adv Exp Med Biol. 2021;1328:513-522.
- Smits MM, Holst JJ. Endogenous glucagon-like peptide (GLP)-1 as alternative for GLP-1 receptor agonists: could this work and how? Diabetes Metab Res Rev. 2023;39(8):e3699.
- Park S, Ahn IS, Kim JH, Lee MR, Kim JS, Kim HJ. Glyceollins, one of the phytoalexins derived from soybeans under fungal stress, enhance insulin sensitivity and exert insulinotropic actions. J Agric Food Chem. 2010;58(3):1551-1557.
- Mietlicki-Baase EG, Koch-Laskowski K, McGrath LE, et al. Daily supplementation of dietary protein improves the metabolic effects of GLP-1-based pharmacotherapy in lean and obese rats. Physiol Behav. 2017;177:122-128.
- Watanabe K, Igarashi M, Li X, et al. Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids. PLoS One. 2018;13(8):e0202083.
- Shin JS, Huh YS. Effect of intake of gardenia fruits and combined exercise of middle-aged obese women on hormones regulating energy metabolism. J Exerc Nutrition Biochem. 2014;18(1):41-49.
- Liu C, Hu M yue, Zhang M, et al. Association of GLP-1 secretion with anti-hyperlipidemic effect of ginsenosides in high-fat diet fed rats. Metabolism. 2014;63(10):1342-1351.
- Wang HP, Lin ZZ, Yin Q, Du J. Screening of GLP-1r agonists from natural products using affinity ultrafiltration screening coupled with UPLC-ESI-Orbitrap-MS technology: a case study of Panax ginseng. J Asian Nat Prod Res. Published online July 22, 2024:1-13.
- Pegah A, Abbasi-Oshaghi E, Khodadadi I, Mirzaei F, Tayebinai H. Probiotic and resveratrol normalize GLP-1 levels and oxidative stress in the intestine of diabetic rats. Metabol Open. 2021;10:100093.
- Thazhath SS, Wu T, Bound MJ, et al. Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. Am J Clin Nutr. 2016;103(1):66-70.
- Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One. 2014;9(3):e91163.
- Karhunen LJ, Juvonen KR, Huotari A, Purhonen AK, Herzig KH. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept. 2008;149(1-3):70-78.
- Thomsen C, Rasmussen O, Lousen T, et al. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr. 1999;69(6):1135-1143.
- Thomsen C, Storm H, Holst JJ, Hermansen K. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr. 2003;77(3):605-611.
- Seery C. Eating avocados as effective as weight loss injections, expert claims. Diabetes.co.uk. Jun 20, 2023.
- Stearn E. I’m a nutritionist—these are the foods that work just like miracle weight loss jab Ozempic. Daily Mail. Jun 9, 2023.
- Corella-Salazar DA, Domínguez-Avila JA, Montiel-Herrera M, et al. Sub-chronic consumption of a phenolic-rich avocado paste extract induces GLP-1-, leptin-, and adiponectin-mediated satiety in Wistar rats. J Food Biochem. 2021;45(11):e13957.
- Haddad E, Wien M, Oda K, Sabaté J. Postprandial gut hormone responses to Hass avocado meals and their association with visual analog scores in overweight adults: a randomized 3 × 3 crossover trial. Eat Behav. 2018;31:35-40.
- Henderson J. What to know about berberine, the supplement dubbed ‘nature’s Ozempic’. ABC News. Jun 15, 2023.
- Yu Y, Liu L, Wang X, et al. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol. 2010;79(7):1000-1006.
- Amini MR, Sheikhhossein F, Naghshi S, et al. Effects of berberine and barberry on anthropometric measures: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;49:102337.
- King K, Lin NP, Cheng YH, Chen GH, Chein RJ. Isolation of positive modulator of glucagon-like peptide-1 signaling from trigonella foenum-graecum (Fenugreek) seed. J Biol Chem. 2015;290(43):26235-26248.
- Chou IW, Cheng YH, Chen YR, Hsieh PCH, King K. Fenugreek compound (N55) lowers plasma glucose through the enhancement of response of physiological glucagon-like peptide-1. Sci Rep. 2017;7(1):12265.
- Li J, Zhang N, Hu L, et al. Improvement in chewing activity reduces energy intake in one meal and modulates plasma gut hormone concentrations in obese and lean young Chinese men. Am J Clin Nutr. 2011;94(3):709-716.
- Kamemoto K, Tataka Y, Hiratsu A, et al. Effect of vegetable consumption with chewing on postprandial glucose metabolism in healthy young men: a randomised controlled study. Sci Rep. 2024;14(1):7557.
- Kokkinos A, le Roux CW, Alexiadou K, et al. Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab. 2010;95(1):333-337.
- Okrent A, Sweitzer M, Young S, Page ET. Researchers Adjust Self-Reported Estimates of Obesity in Scanner Data. USDA Economic Research Service. Nov 20, 2023.
- Rigamonti AE, Agosti F, Compri E, et al. Anorexigenic postprandial responses of PYY and GLP1 to slow ice cream consumption: preservation in obese adolescents, but not in obese adults. Eur J Endocrinol. 2013;168(3):429-436.
- Haldar S, Chia SC, Henry CJ. Polyphenol-rich curry made with mixed spices and vegetables increases postprandial plasma GLP-1 concentration in a dose-dependent manner. Eur J Clin Nutr. 2018;72(2):297-300.
- Samad MB, Mohsin MNAB, Razu BA, et al. [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Leprdb/db type 2 diabetic mice. BMC Complement Altern Med. 2017;17(1):395.
- Al Asoom L, Alassaf MA, AlSulaiman NS, et al. The effectiveness of nigella sativa and ginger as appetite suppressants: an experimental study on healthy Wistar rats. Vasc Health Risk Manag. 2023;19:1-11.
- Hu ML, Rayner CK, Wu KL, et al. Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J Gastroenterol. 2011;17(1):105-110.
- Sharma P, Joshi T, Joshi T, Chandra S, Tamta S. In silico screening of potential antidiabetic phytochemicals from Phyllanthus emblica against therapeutic targets of type 2 diabetes. J Ethnopharmacol. 2020;248:112268.
- Thota RN, Dias CB, Abbott KA, Acharya SH, Garg ML. Curcumin alleviates postprandial glycaemic response in healthy subjects: a cross-over, randomized controlled study. Sci Rep. 2018;8(1):13679.
- Takikawa M, Kurimoto Y, Tsuda T. Curcumin stimulates glucagon-like peptide-1 secretion in GLUTag cells via Ca2+/calmodulin-dependent kinase II activation. Biochem Biophys Res Commun. 2013;435(2):165-170.
- He Y, Chen X, Li Y, et al. Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial. Am J Clin Nutr. 2024;120(1):66-79.
- Hlebowicz J, Hlebowicz A, Lindstedt S, et al. Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects. Am J Clin Nutr. 2009;89(3):815-821.
- Smeets AJ, Westerterp-Plantenga MS. The acute effects of a lunch containing capsaicin on energy and substrate utilisation, hormones, and satiety. Eur J Nutr. 2009;48(4):229-234.
- Zuluaga G. Potential of bitter medicinal plants: a review of flavor physiology. Pharmaceuticals (Basel). 2024;17(6):722.
- Walker EG, Lo KR, Pahl MC, et al. An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial. Am J Clin Nutr. 2022;115(3):925-940.
- Latorre R, Huynh J, Mazzoni M, et al. Expression of the bitter taste receptor, T2R38, in enteroendocrine cells of the colonic mucosa of overweight/obese vs. Lean subjects. PLoS One. 2016;11(2):e0147468.
- Rezaie P, Bitarafan V, Rose BD, et al. Quinine effects on gut and pancreatic hormones and antropyloroduodenal pressures in humans-role of delivery site and sex. J Clin Endocrinol Metab. 2022;107(7):e2870-e2881.
- Walker E, Lo K, Tham S, et al. New Zealand bitter hops extract reduces hunger during a 24 h water only fast. Nutrients. 2019;11(11):2754.
- George JN, Morton JM, Liles NW, Nester CM. After the party’s over. N Engl J Med. 2017;376(1):74-80.
- Bitarafan V, Fitzgerald PCE, Little TJ, et al. Intragastric administration of the bitter tastant quinine lowers the glycemic response to a nutrient drink without slowing gastric emptying in healthy men. Am J Physiol Regul Integr Comp Physiol. 2020;318(2):R263-R273.
- Heybach JP, Boyle PC. Dietary quinine reduces body weight and food intake independent of aversive taste. Physiol Behav. 1982;29(6):1171-1173.
- Iven J, Biesiekierski JR, Zhao D, et al. Intragastric quinine administration decreases hedonic eating in healthy women through peptide-mediated gut-brain signaling mechanisms. Nutr Neurosci. 2019;22(12):850-862.
- Saguil A, Lauters R. Quinine for leg cramps. Am Fam Physician. 2016;93(3):177-178.
- Quinine-containing beverages may cause health problems. BfR. Feb 17, 2005.
- Andreozzi P, Sarnelli G, Pesce M, et al. The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects. J Neurogastroenterol Motil. 2015;21(4):511-519.
- Chiurazzi M, De Conno B, Di Lauro M, et al. The effects of a cinchona supplementation on satiety, weight loss and body composition in a population of overweight/obese adults: a controlled randomized study. Nutrients. 2023;15(24):5033.
- Brasić JR. Risks of the consumption of beverages containing quinine. Psychol Rep. 2003;93(3 Pt 2):1022-1024.
- Andreozzi P, Sarnelli G, Pesce M, et al. The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects. J Neurogastroenterol Motil. 2015;21(4):511-519.
- Chiurazzi M, De Conno B, Di Lauro M, et al. The effects of a cinchona supplementation on satiety, weight loss and body composition in a population of overweight/obese adults: a controlled randomized study. Nutrients. 2023;15(24):5033.
- Brasić JR. Risks of the consumption of beverages containing quinine. Psychol Rep. 2003;93(3 Pt 2):1022-1024.
- Liles NW, Page EE, Liles AL, Vesely SK, Raskob GE, George JN. Diversity and severity of adverse reactions to quinine: a systematic review. Am J Hematol. 2016;91(5):461-466.
- Brasić JR. Should people with nocturnal leg cramps drink tonic water and bitter lemon? Psychol Rep. 1999;84(2):355-367.
- Howard MA, Hibbard AB, Terrell DR, Medina PJ, Vesely SK, George JN. Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent). 2003;16(1):21-26.
- Bohne AS, Dietrich C, Morrison K, Schwarz T, Wehkamp U, Kaeding M. Two cases of quinine-induced fixed “drug” eruption induced by long drinks. J Eur Acad Dermatol Venereol. 2021;35(11):e774-e776.
- Lonsdale-Eccles E, Wallett A, Ward AM. A case of fixed drug eruption secondary to quinine in tonic water presenting to a sexual health clinic. Sex Transm Infect. 2014;90(5):356-357.
- Wada S, Namiki T, Tokoro S, Miura K, Yokozeki H. Stevens-Johnson syndrome induced by tonic water. J Eur Acad Dermatol Venereol. 2021;35(10):e662-e663.
- Gelfman DM. Reflections on quinine and its importance in dermatology today. Clin Dermatol. 2021;39(5):900-903.
- Osinubi AA, Noronha CC, Okanlawon AO. Morphometric and stereological assessment of the effects of long-term administration of quinine on the morphology of rat testis. West Afr J Med. 2005;24(3):200-205.
- Taylor S. Quinine intoxications: a continuing problem. Br J Clin Pharmacol. 2004;57(6):817; author reply 817.
- Bacon P, Spalton DJ, Smith SE. Blindness from quinine toxicity. Br J Ophthalmol. 1988;72(3):219-224.
- El-Tawil S, Al Musa T, Valli H, et al. Quinine for muscle cramps. Cochrane Database Syst Rev. 2015;2015(4):CD005044.
- Drug Products Containing Quinine; Enforcement Action Dates. FederalRegister.gov. Dec 15, 2006.
- Serious risks associated with using Quinine to prevent or treat nocturnal leg cramps. US FDA. Sept 2012.
- Moshirfar M, Somani SN, Shmunes KM, Ronquillo YC. Will tonic water stop my eyelid twitching? Clin Ophthalmol. 2020;14:689-691.
- Traill A. Quinine iris toxicity. Arch Ophthalmol. 2007;125(3):430.
- Worden AN, Frape DL, Shephard NW. Consumption of quinine hydrochloride in tonic water. Lancet. 1987;1(8527):271-272.
- Berglund F. Toxicity of quinine. Toxicology. 1989;58(3):237-238.
- Horgan SE, Williams RW. Chronic retinal toxicity due to quinine in Indian tonic water. Eye (Lond). 1995;9(Pt 5):637-638.
- Elmusa E, Asghar H, Hamza A, Raza MW, Rodriguez I. Quinine water-triggered atrial tachyarrhythmia. Cureus. 2022;14(12):e32706.
- Drewitt PN, Butterworth KR, Springall CD, Walters DG, Raglan EM. Toxicity threshold of quinine hydrochloride following low-level repeated dosing in healthy volunteers. Food Chem Toxicol. 1993;31(4):235-245.
- Colley JC, Edwards JA, Heywood R, Purser D. Toxicity studies with quinine hydrochloride. Toxicology. 1989;54(2):219-226.
- Duncan ADS, Hapca S, De Souza N, Morales D, Bell S. Quinine exposure and the risk of acute kidney injury: a population-based observational study of older people. Age Ageing. 2020;49(6):1042-1047.
- Fardet L, Nazareth I, Petersen I. Association between long-term quinine exposure and all-cause mortality. JAMA. 2017;317(18):1907-1909.
- Ohira A, Yamaguchi S, Miyagi T, et al. Fixed eruption due to quinine in tonic water: a case report with high-performance liquid chromatography and ultraviolet A analyses. J Dermatol. 2013;40(8):629-631.
- Marques JG, Calado G, Martins P, Pinto PL. Tonic water: a rare cause of exanthema. Allergol Immunopathol (Madr). 2012;40(1):60-61.
Vuoi saperne di più? Contattaci